Identification of Sjögren's syndrome oral fluid biomarker candidates following high-abundance protein depletion

Rheumatology (United Kingdom)

Volumn 54, Issue 5, 2014, Pages 884-890

  Deutsch, Omer ^a   Krief, Guy ^a   Konttinen, Yrjö T ^b,c,d   Zaks, Batia ^a   Wong, David T ^e   Aframian, Doron J ^a   Palmon, Aaron ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c ORTON ORTHOPAEDIC HOSPITAL   (Finland)

^d University of Tampere   (Finland)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Biomarker; Oral fluid; Protein depletion; Salivary gland; Sj gren's syndrome

Indexed keywords

ALPHA 1 ANTITRYPSIN; BIOLOGICAL MARKER; CALCIUM BINDING PROTEIN; CALGRANULIN A; CARBONATE DEHYDRATASE I; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; CATALASE; CHITOTRIOSIDASE; COMPLEMENT COMPONENT C3; CYSTATIN S; DESMOGLEIN 3; FRUCTOSE BISPHOSPHATE ALDOLASE; GELATINASE B; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HISTONE H2B; HISTONE H4; IMMUNOGLOBULIN G; KALLIKREIN; KERATIN TYPE I; LEUKOCYTE ELASTASE; OROSOMUCOID; PHOSPHOGLUCONATE DEHYDROGENASE; PREALBUMIN; PROFILIN; PROTEIN 14 3 3; PSORIASIN; STEFIN A; THROMBOPLASTIN; TRANSGELIN;

ADULT; APOPTOSIS; ARTICLE; BIOINFORMATICS; BODY FLUID; CELL MOTION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; MIDDLE AGED; ORAL FLUID; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEOMICS; SJOEGREN SYNDROME; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

EID: 84929664475     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keu405     Document Type: Article

References (20)

1. Ryu OH, Atkinson JC, Hoehn GT, Illei GG, Hart TC. Identification of parotid salivary biomarkers in Sjogren's syndrome by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry and twodimensional difference gel electrophoresis. Rheumatology 2006;45:1077-86.
2. Vitali C, Bombardieri S, Jonsson R et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.
3. Fleissig Y, Deutsch O, Reichenberg E et al. Different proteomic protein patterns in saliva of Sjogren's syndrome patients. Oral Dis 2009;15:61-8.
4. Krief G, Deutsch O, Gariba S et al. Improved visualization of low abundance oral fluid proteins after triple depletion of alpha amylase, albumin and IgG. Oral Dis 2011;17:45-52.
5. Hu S, Gao K, Pollard R et al. Preclinical validation of salivary biomarkers for primary Sjogren's syndrome. Arthritis Care Res 2010;62:1633-8.
6. Hjelmervik TO, Jonsson R, Bolstad AI. The minor salivary gland proteome in Sjogren's syndrome. Oral Dis 2009;15:342-53.
7. Ferraccioli G, De Santis M, Peluso G et al. Proteomic approaches to Sjogren's syndrome: a clue to interpret the pathophysiology and organ involvement of the disease. Autoimmun Rev 2010;9:622-6.
8. Peluso G, De Santis M, Inzitari R et al. Proteomic study of salivary peptides and proteins in patients with Sjogren's syndrome before and after pilocarpine treatment. Arthritis Rheum 2007;56:2216-22.
9. Giusti L, Baldini C, Bazzichi L et al. Proteome analysis of whole saliva: a new tool for rheumatic diseases-the example of Sjogren's syndrome. Proteomics 2007;7:1634-43.
10. Hu S, Wang J, Meijer J et al. Salivary proteomic and genomic biomarkers for primary Sjogren's syndrome. Arthritis Rheum 2007;56:3588-600.
11. Quintana M, Palicki O, Lucchi G et al. Inter-individual variability of protein patterns in saliva of healthy adults. J Proteomics 2009;72:822-30.
12. Cooper T, Savige J, Nassis L et al. Clinical associations and characterisation of antineutrophil cytoplasmic antibodies directed against bactericidal/permeability-increasing protein and azurocidin. Rheumatol Int 2000;19:129-36.
13. Botre F, Botre C, Podesta E, Podda M, Invernizzi P. Effect of anti-carbonic anhydrase antibodies on carbonic anhydrases I and II. Clin Chem 2003;49:1221-3.
14. Campostrini N, Areces LB, Rappsilber J et al. Spot overlapping in two-dimensional maps: a serious problem ignored for much too long. Proteomics 2005;5:2385-95.
15. Wittenmayer N, Jandrig B, Rothkegel M et al. Tumor suppressor activity of profilin requires a functional actin binding site. Mol Biol Cell 2004;15:1600-8.
16. Unger A, Panayi GS, Lessof MH. Carcinoembryonic antigen in rheumatic diseases. Rheumatol Rehabil 1975;14:19-24.
17. Kanehisa M, Goto S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res 2000;28:27-30.
18. Ito K, Funayama S, Hitomi Y et al. Proteome analysis of gelatin-bound salivary proteins in patients with primary Sjogren's syndrome: identification of matrix metalloproteinase-9. Clin Chim Acta 2009;403:269-71.
19. Milovanovic M, Nilsson E, Jaremo P. Relationships between platelets and inflammatory markers in rheumatoid arthritis. Clin Chim Acta 2004;343:237-40.
20. Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009;4:44-57.